Teva to Present at the Bank of America Merrill Lynch 2013 Health Care Conference
JERUSALEM--(BUSINESS WIRE)-- Teva Pharmaceutical Industries Ltd. (NYSE: TEVA ) will host a live audio webcast at the Bank of America Merrill Lynch 2013 Health Care Conference in Las Vegas, NV. Jon Congleton, Senior Vice President and General Manager, Global CNS will present on Wednesday, May 15, 2013.
|Teva Presentation at the Bank of America Merrill Lynch 2013 Health Care Conference|
|Jon Congleton, Senior Vice President and General Manager, Global CNS, Teva Pharmaceutical Industries Ltd.|
|Wednesday, May 15, 2013 at 2:20 PM (PT)|
|Live over the Internet – log on to the Web at the address above and register for the event (approximately 10 minutes before). An archive of the webcast will be available on Teva’s website.|
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA ) is a leading global pharmaceutical company, committed to increasing access to high-quality healthcare by developing, producing and marketing affordable generic drugs as well as innovative and specialty pharmaceuticals and active pharmaceutical ingredients. Headquartered in Israel, Teva is the world's leading generic drug maker, with a global product portfolio of more than 1,000 molecules and a direct presence in about 60 countries. Teva's branded businesses focus on CNS, oncology, pain, respiratory and women's health therapeutic areas as well as biologics. Teva currently employs approximately 46,000 people around the world and reached $20.3 billion in net revenues in 2012.
Kevin C. Mannix
972 (3) 926-7656
Iris Beck Codner
972 (3) 926-7246
KEYWORDS: United States North America Nevada Middle East Israel